Idiopathic thrombocytopenic purpura associated with mantle cell lymphoma showing an increase in the platelet count receiving anti-CD20 antibody rituximab.
FINK, K. Idiopathic thrombocytopenic purpura in lymphoma. Cancer. 1976, 37, 1999-2004
STASIS, R. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood. 2001, 98, 952-957
ARISTOTELES, AN. Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 antibody rituximab. Blood. 2001, 98, 523a
STASIS, R. . Variable patterns of response to rituximab treatment in adults with chronic adiopathic thrombocytopenic purpura. Blood. 2002, 99, 3872-3873
SHVIDEL, L. Successful treatment with Rituximab for relapsing immune thrombocytopenic purpura (ITP) associated with low-grade non-Hodgkin's lymphoma. Amer J Hematol. 2001, 67, 213-214